Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

News last week including US biotechs Alumis and Acelyrin announcing that they are merging to create a late-stage clinical ...

Everything we covered on WTR over the past seven days, and all you need to know from the world of trademarks to set yourself ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Novo Nordisk and Eli Lilly have used submissions to the federal government’s budget process to argue reducing obesity will be ...